L&G PHARMA BREAKTHROUGH UCITS ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.152 USD | -0.59% |
|
+0.94% | -13.14% |
| 2018 | ETFS Pharma Breakthrough GO UCITS ETF has Changed its Name to L&G Pharma Breakthrough UCITS ETF | CI |
Investment objective
The L&G Pharma Breakthrough UCITS ETF (the 'ETF') aims to track the performance of the Solactive Pharma Breakthrough Value Index (the 'Index').
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 279.6 SEK | -0.43% | +6.82% | +4.42% | 4.51% | ||
| 4,852 JPY | -0.16% | -1.40% | -9.17% | 4.07% | ||
| 42.02 USD | +0.43% | +3.71% | -16.60% | 4.01% | ||
| 28.75 EUR | -0.24% | +9.83% | -29.84% | 3.95% | ||
| 39.15 HKD | +1.56% | +17.92% | -8.42% | 3.82% | ||
| 397.3 USD | -0.09% | +0.77% | -2.35% | 3.73% | ||
| 2.77 HKD | +1.09% | +18.38% | -20.17% | 3.67% | ||
| 15.7 USD | -0.29% | +12.58% | -42.04% | 3.36% | ||
| 81.74 USD | -0.53% | -7.94% | -15.38% | 3.36% | ||
| 4.45 HKD | +1.37% | +9.61% | -35.41% | 3.34% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 9.152 | -0.59% | 15 |
| 24-04-24 | 9.206 | -0.66% | 0 |
| 24-04-23 | 9.268 | +1.61% | 2,064 |
| 24-04-22 | 9.121 | +0.92% | 0 |
| 24-04-19 | 9.038 | -0.33% | 0 |
Other stock markets
Delayed Quote London S.E.
Last update April 25, 2024 at 11:35 am EDT
More quotesDescription
| IE00BF0H7608 | |
|---|---|
| Total Expense Ratio | 0.49% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Solactive Pharma Breakthrough Value NTR Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2018-01-22
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-03-27 )
| AuM (EUR) | 20 M€ |
|---|---|
| AuM 1M | 21 M€ |
| AuM 3 months | 26 M€ |
| AuM 6 months | 43 M€ |
| AuM 12 months | 59 M€ |
- Stock Market
- ETF
- BIGT ETF
